William N Haining

This inventor holds 6 USPTO granted patents and 4 published patent applications and 1 EPO patent. Top assignees: Dana-Farber-Cancer Institute Inc., Harvard College. Active years: 2020-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: William N Haining. Retrieved from https://idiyas.com/inventor/william-n-haining

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 6 (Patent Applications = 4)

% Patents Active = 100.0

EPO Patents = 1 (Patent Applications = 1)

Average Co-Inventor Count = 3.2

ph-index = 1

Company Filing History:

6 out of 1,268

Dana-Farber-Cancer Institute Inc.

where one patent can have more than one assignee

Years Active: 2020-2024

Loading Chart...

6 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12050219 - Modulating biomarkers such as SPP to increase tumor immunity and improve the efficacy of cancer immunotherapy (2024-07-30),

2. 11873486 - Modulating dsRNA editing, sensing, and metabolism to increase tumor immunity and improve the efficacy of cancer immunotherapy and/or modulators of intratumoral interferon (2024-01-16),

3. 11740242 - Modulating biomarkers to increase tumor immunity and improve the efficacy of cancer immunotherapy (2023-08-29),

4. 11179480 - In vivo methods for identifying cancer-associated immunotherapy targets (2021-11-23),

5. 10927410 - Compositions and methods for identification, assessment, prevention, and treatment of T-cell exhaustion using CD39 biomarkers and modulators (2021-02-23),

6. 10653123 - Methods and compositions for perturbing gene expression in hematopoietic stem cell lineages in vivo (2020-05-19),

Title: William N Haining: Innovator in Cancer Immunotherapy

Introduction

William N Haining is a prominent inventor based in Newton, MA (US), known for his significant contributions to cancer immunotherapy. With a total of 6 patents, Haining has focused on developing innovative methods to enhance tumor immunity and improve the efficacy of cancer treatments.

Latest Patents

Haining's latest patents include groundbreaking inventions aimed at modulating biomarkers to increase tumor immunity. One of his notable patents involves methods of treating cancer by administering agents that modulate biomarkers, such as inhibiting or increasing specific biomarkers in combination with immunotherapy. Another significant patent focuses on modulating dsRNA editing, sensing, and metabolism to enhance tumor immunity. This invention outlines methods for treating cancer by targeting the expression levels and activity of various biomarkers, as well as detecting dependencies in high proliferation cells.

Career Highlights

Throughout his career, Haining has worked with esteemed institutions, including the Dana-Farber Cancer Institute and Harvard College. His work has been pivotal in advancing the understanding of cancer biology and developing novel therapeutic strategies.

Collaborations

Haining has collaborated with notable colleagues, including Robert Manguso and Arlene Helen Sharpe, contributing to a rich environment of innovation and research in cancer immunotherapy.

Conclusion

William N Haining's contributions to cancer immunotherapy through his patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for advancements in cancer treatment and patient care.

Profile summary based on public USPTO records.